What Happened?
Shares of health insurance company Clover Health (NASDAQ: CLOV) jumped 13.6% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat analysts' EPS expectations and included full-year EBITDA guidance above Wall Street estimates. On the other hand, while membership in their Medicare Advantage plans jumped 30%, pushing revenue up 33%, sales still came in just under what analysts expected. Overall, we think this was a decent quarter with some key metrics above expectations.
Is now the time to buy Clover Health? Access our full analysis report here, it’s free.
What The Market Is Telling Us
Clover Health’s shares are extremely volatile and have had 54 moves greater than 5% over the last year. But moves this big are rare even for Clover Health and indicate this news significantly impacted the market’s perception of the business.
Clover Health is up 21.6% since the beginning of the year, but at $3.81 per share, it is still trading 21.1% below its 52-week high of $4.82 from January 2025. Investors who bought $1,000 worth of Clover Health’s shares at the IPO in June 2020 would now be looking at an investment worth $373.04.
Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free and will only take you a second.
